To assess whether AMPK provided protection against cell death induced by cordycepin, we utilized double-knockout (AMPK DKO) human osteosarcoma (U2OS) cells in which both the α1 and the α2 catalytic subunit isoforms had been knocked out using CRISPR. This evidence concerns the gene PRKAA2 and osteosarcoma.